While growth drivers varied for specific companies in Q122, the return of elective procedure volumes helped drive double-digit growth for several market players. Stryker*, the Extremities Market leader, benefited from the return of elective procedures in the US. Its US Foot & Ankle and Upper Extremities business segments contributed to the Company’s US Trauma & Extremities growth during the quarter. Stryker also noted during its earnings call that ...
Among the many topics covered in detail in our comprehensive Q122 Extremities Market Recap* are:
Deals in the Extremities space outpaced 2021 with three acquisitions completed in the first quarter of 2022 and a strategic partnership. Acquisitions were completed in each month of the quarter. In January, Paragon 28 acquired ...
*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.